Started 3rd pBAT cycle on 6-4-24 with a PSA of 0.58 measured 1 day earlier, 32 days after last of 6 T injections. Started 4th cycle on 7-26-24 with a PSA of 0.59 measured 2 days earlier, 34 days after last of 9 T injections. Tomorrow I will start my first loT phase with darolutamide (see below question for my fellow BAT-men) with a PSA of 2.25 measured 7 hours after the last of 11 T injections.
6-20-24, end of 3rd hiT cycle (9 injections):
PSA = 2.17 (similar to previous 3 hiT cycles)
T = 1346 (drawn approximately 48 hrs after 8th T injection, delayed to check Tp half-life)
E2 <15 (took a single .0625 dose of letrozole, will eliminate this on the next hiT cycle)
7-24-24, end of 3rd loT cycle, 34 days after last T injection:
PSA = 0.59 (similar to previous cycles)
E2 = 13 (target is 20, so will increase # of days on low dose E2 patch)
8-16-24, end of 4th hiT cycle, drawn 7 hours after 11th T injection:
PSA = 2.25
E2 ultrasensitive pending
I recently obtained a script for daro (Nubeqa) from my MO. I plan to take a half dose (300 mg) twice daily for the 1st 2 weeks of loT and then measure PSA. Regardless of the result, I plan to wait another week or two and re-measure since this is my first cycle using daro. If PSA is not well under 0.5 (target is <0.1) after 4 weeks, I may have to increase the dose on the next cycle, assuming that I’m handling the SE’s okay.
Sound reasonable?